Proteolix

About:

Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies

Website: http://www.proteolix.com

Top Investors: U.S. Venture Partners, Advanced Technology Ventures, The Vertical Group, Latterell Venture Partners, Westfield Capital Management

Description:

Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.

Total Funding Amount:

$142M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)proteolix.com

Founders:

Phil Whitcome, Ray Deshaies, Raymond Deshaies

Number of Employees:

10001+

Last Funding Date:

2008-09-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai